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 Neuronal Nicotinic Receptors (NNRs) are ligand gated ion channels located both 
pre- and postsynaptically in the peripheral and central nervous systems. NNRs are 
important pharmaceutical targets for schizophrenia, pain, epilepsy, tobacco dependence, 
Tourette’s syndrome, Alzheimer’s disease, Parkinson’s disease, myasthenia gravis, and 
depression.1, 2  Rational drug design for NNRs has been hampered by the lack of 
crystallographic information about this important target. Currently, there exist two atomic-
level structures representing NNR subtypes. The first a cryoelectron micrograph of a 
muscle NNR3 at 4 Å resolution provided initial structural information about the complete 
receptor. A more recent crystal structure of the extracellular domain of the mouse 
nicotinic acetylcholine receptor (NNR) α1 subunit bound to α-bungarotoxin at 1.94 Å 
resolution is the first atomic-resolution view of a NNR subunit extracellular domain.2  
Other receptor structural data has arisen from acetylcholine binding proteins (AChBPs) 4, 
5 isolated from freshwater and marine snails. AChBPs are water-soluble proteins, which 
are homologues of the extracellular domain of the NNRs.  
 Information collected during this project will be used to aid in the development of 
homology models for various NNR subtypes, based on a more complete understanding 
of AChBPs. To this end, available co-crystal structures were analyzed through 
measurement of distances and angles between residues that make up the ligand binding 
domain (LBD). Further, to evaluate the utility of various docking/scoring algorithms 
docking studies were performed on these AChBP co-crystal structures. Nineteen NNR 
ligands were docked into the AChBPs using Schrodinger’s Glide 5.0 software.  
 
 A few of the key findings of this research are as follows. First, careful 
examination of the various geometric parameters shows that large changes occur to the 
AChBP LBD as a ligand binds. These changes include a 15 residue C-loop closing over 
the LBD with a concomitant movement of the two subunits that make up the LBD relative 
to each other to accommodate the ligand.  The latter is illustrated by changes in the chi 1 
and chi 2 of tyrosine (Y) 55 (from the complementary face) and changes in the chi 1 of 
tyrosine (Y) 93 in the lobeline AChBP to make room in the LBD for one of the phenyl 
rings on lobeline. Second, results from the docking studies on all available AChBP-co-
crystal structure suggest that the AChBP lobeline structure is the best template for 
homology modeling based on the following: (1)  Glide 5.0 was able to dock most of a 
diverse set of 19 NNR ligands into this structure, in contrast to more limited success for 
other AChBP starting points; (2) in cases where the crystal structure had been 
determined, poses similar to those found for the actual co-crystal structure could be 
reproduced; (3) the correlation between the Glide score (Gscore) for these expected 
poses and experimental pKd values was (while still modest) best for this structure 
(correlation, 0.30);  (4) correlation between the best Gsore and the pKd was highest for 
the lobeline AChBP structure (R2 = 0.38). The lobeline AChBP structure is now under 
investigation as a template to generate homology models to aid in drug discovery at 
Targacept.   
 
 
 
STRUCTURAL CHARACTERIZATION AND DOCKING STUDIES  
OF ACETYLCHOLINE BINDING PROTEINS 
 
 
 
 
By 
 
Leona Ravini Sirkisoon 
 
 
 
A Thesis Submitted to 
the Faculty of The Graduate School at 
The University of North Carolina at Greensboro 
in Partial Fulfillment 
of the Requirements for the Degree 
Master of Science 
 
 
 
Greensboro 
2009 
 
 
 
 Approved by 
 
 
 
 
 ________________________________ 
 Committee Chair 
ii 
 
APPROVAL PAGE 
This thesis has been approved by the following committee of the Faculty of The 
Graduate School at The University of North Carolina at Greensboro. 
 
 
 
 
 
 Committee Chair _____________________________________ 
 Patricia H. Reggio 
 
 
 Committee Members _____________________________________ 
 Philip S. Hammond 
  
 
  _____________________________________ 
  J. Phillip Bowen 
 
 
 
 
 
April 28th, 2009 
___________________________ 
Date of Acceptance by Committee 
 
 
April 13th, 2009 
___________________________ 
Date of Final Oral Examination 
 
  
iii 
 
ACKNOWLEDGEMENTS 
 
I would like to thank Dr. Patricia H. Reggio, Dr. Philip S. Hammond and Dr. J. Phillip 
Bowen for all the help provided and for serving on my committee. I would also like to 
thank Targacept Inc. for providing assistantship support for this work. 
 
iv 
 
TABLE OF CONTENTS 
Page 
LIST OF TABLES ............................................................................................................ v 
LIST OF FIGURES ......................................................................................................... vi 
CHAPTER 
  I. LITERATURE REVIEW .......................................................................................... 1 
 Importance of Neuronal Nicotinic Receptors ................................................. 1 
 Crystal Structures Available .......................................................................... 3 
 Sequence Alignment ..................................................................................... 4 
Acetylcholine Binding Protein and Neuronal Nicotinic Receptor     
Comparison .............................................................................................. 5 
 
 II. INTRODUCTION ..................................................................................................10 
 Hypotheses ..................................................................................................10 
 Goals ...........................................................................................................11 
III. PROCEDURES .....................................................................................................12 
Aim 1. AChBP Geometrical Analysis Using Maestro V 7.5                       
(Schrodinger, Inc.) and Discovery Studio 2.0 (Accelrys) ...............12 
 Aim 2. AChBP Docking Studies ....................................................................14 
 Aim 3. Scoring Functions .............................................................................19 
IV. RESULTS .............................................................................................................20 
 AChBP Geometrical Analysis .......................................................................20 
 AChBP Docking Studies ...............................................................................31 
 V. CONCLUSION ......................................................................................................55 
 General Conclusion ......................................................................................55 
 Future Studies ..............................................................................................56 
REFERENCES ..............................................................................................................58 
APPENDIX  DISTANCES MEASURED .........................................................................60 
 
v 
 
LIST OF TABLES 
 
Page 
Table 1. NNR Ligand Dataset ........................................................................................16 
Table 2. W147 to I118 Measurements ...........................................................................28 
Table 3. Crystal Structure Ligands Docked Without Explicit Water ................................32 
Table 4. Crystal Structure Ligands Docked With Explicit Water .....................................34 
Table 5. A-Lob Other Scoring Functions ........................................................................52 
Table 6. L-Hepes  Other Scoring Functions ...................................................................53 
 
  
vi 
 
LIST OF FIGURES 
Page 
Figure 1.Torpedo mamorata Nicotinic Receptor Side and Top View ............................... 2 
Figure 2. Sequence Alignment ....................................................................................... 4 
Figure 3. Nicotinic Receptor and Apo AChBP Monomer Comparison ............................. 6 
Figure 4. C-Loop Movement ........................................................................................... 7 
Figure 5. Ligands co-crystallized with Aplysia AChBP. ................................................... 8 
Figure 6. Ligands co-crystallized with Lymnaea AChBP. ................................................ 8 
Figure 7. Apo AChBP and NNR Pentamer Comparison ................................................. 9 
Figure 8. Ligand binding domain residues. ....................................................................20 
Figure 9. Binding Site Distances Measured ...................................................................22 
Figure 10. Definition of Chi1 and Chi2 angles. ...............................................................23 
Figure 11. Chi1 Angles ..................................................................................................24 
Figure 12. Chi2 Angles. .................................................................................................25 
Figure 13. Distances from the Ligand Cationic Center to Binding Site Residues ...........26 
Figure 14. Angles from the Ligand Cationic Center to Binding Site Residues ................26 
Figure 15. Complementary Face Changes Relative to the Principal Face .....................28 
Figure 16. Distances Between the Prinicpal and Complementary Faces .......................30 
Figure 17. Distances Between the Prinicpal and Complementary Faces Averaged .......30 
Figure 18. Docking Results for Ac-Apo Without Explicit Water ......................................39 
Figure 19. Docking Results for Ac-Epe Without Explicit Water ......................................41 
Figure 20. Docking Results for Ac-Lob Without Explicit Water .......................................43 
Figure 21. Docking Results for Ac-Lob Without Explicit Water—Lobeline Point   
Removed .................................................................................................45 
Figure 22. Docking Results for Ac-Epi Without Explicit Water ........................................47 
vii 
 
Figure 23. Docking Results for Ls-Nic Without Explicit Water ........................................49 
Figure 24. QPLD Gscore vs. pKd Graph ........................................................................52 
Figure 25. Distances Measured—Complementary to Figure 9. ......................................60 
 
 
  
1 
 
 
CHAPTER I 
 
LITERATURE REVIEW 
Importance of Neuronal Nicotinic Receptors 
Nicotinic acetylcholine receptors (NNRs) are transmembrane cation channels and 
members of the ligand gated ion channel (LGIC) family.4,3 NNRs mediate cationic flux 
across cell membranes,4 allowing sodium (Na+), potassium (K+) and calcium (Ca2+) ions 
to flow into the cell but not out.3,6 NNRs function by depolarizing the cell membrane, with 
subsequent activation of K+ channels.7,8 NNRs are found in ganglia and in 
neuromuscular junctions, as well as in the central nervous system (CNS),3,2 are made up 
of five subunits, and exist as both hetero- and homopentamers.  A variety of different 
subunit types have been identified, designated α2-α10, β2-β4, γ and δ/ε6 and these may 
combine in a variety of ways,  leading to a number of receptor subtypes based on 
various subunit combinations.   
NNRs are activated by the endogenous neurotransmitter acetylcholine, by the 
prototypical ligand nicotine as well as by other agonists.  Ligand binding of agonists and 
antagonists occurs at the outside midsection of the extracellular domain (ECD), with 
resulting pore opening and ion flow through the channel, or blockade of the receptor.3 
Based on their extensive anatomical distribution and their ability to pre-synaptically 
modulate a variety of signaling processes, neuronal nicotinic receptors (NNRs) are a 
target for drug discovery because of their potential to impact various CNS diseases and 
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disorders. NNRs have been extensively validated as therapeutic targets for various CNS 
pathologies such as schizophrenia, anxiety, epilepsy, depression, analgesia, addiction 
disorders, Alzeihmer disease, Parkinson disease and inflammation.1,9,10,11 Chantix®, a 
compound targeted at the human α4β2 receptor, is currently on the market (Pfizer) for 
smoking cessation. 
 
 
 
 
 
 
 
 
Figure 1. Torpedo mamorata Nicotinic Receptor Side and Top View . Similar to image in Unwin, 
N. J. Mol. Biol. 2005, 346, 967-989.  a: extracellular, transmembrane and intracellular domains, and 
possible gate locations. b:  receptor viewed from the extracellular domain and looking down the pore 
opening, with views for the five different subunits. 
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Crystal Structures Available 
Currently, there exist two atomic-level structures representing nicotinic receptor 
subtypes, a 4 Å resolution of the heteropentameric muscle-type receptor shown in 
Figure 13 and a single α1 subunit at 1.94 Å resolution.2  Structurally, in addition to the 
ligand-binding site where competitive agonists and antagonists interact, there are 
several other areas of interest in the receptor structure. Evidence suggests that the ion 
channel gate may be located in two possible locations: the middle of the transmembrane 
helices (TMH); or, at the intracellular end of the pore (Figure 1a).12 Further, allosteric 
modulators (both potentiators and inhibitors) are an important class of ligands that 
interact with the NNRs, perhaps at several sites non-concurrent with the competitive 
agonist and antagonist site. 
  Other receptor structural data has arisen from acetylcholine binding proteins 
(AChBPs),13 water soluble homologues of the NNRs ECD. These proteins, like the 
homopentameric NNRs, show five separate ligand binding domains (LBDs) and interact 
with NNR ligands, as shown by co-crystallization with both NNR agonists and 
antagonists.4,5  AChBPs have been isolated from Lymnaea stagnalis (Great Pond Snail), 
Aplysia californica (California Sea Hare) and Bulinus truncatus, L-, A- and B-AChBP 
respectively.13,4,5,14 To date, only the Aplysia and Lymnaea AChBPs have been co-
crystallized with NNR ligands. It is also of note that coupling a modified version of L-
AChBP with the transmembrane region of the 5-HT3A receptor was reported to provide a 
functional NNR analog.15   
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Sequence Alignment 
Overall, AChBPs show only modest sequence similarity to LGICs (15-28%)4  but 
do show very similar characteristics to the NNR LBDs.  Sequence alignment of L- , B- 
and A-AChBP, along with the α4, β2 and α7 subunits of the human NNRs are shown in 
Figure 2. The sequence alignment was generated using Clustal W from San Diego 
Supercomputer Center (SDSC) Biology Workbench. 
 
 
 
 
 
 
 
 
Figure 2. Sequence Alignment.  Sequence alignment between Lymnaea, Aplysia and Bulinus AChBP and 
Human α4, α7 and β2 subunits. Identical, strongly similar and weakly similar residues are identified by pink, 
green and blue backgrounds, respectively. A white background designates nonmatching residues. The LBD 
residues are marked by a diamond with red diamonds indicating the residues on the principal face and 
purple diamonds from the complementary face. 
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Acetylcholine Binding Protein and Neuronal Nicotini c Receptor 
Comparison 
Based on co-crystal structures as well as an apo form of the aplysia AChBP 
(where the LBDs are weakly occupied5) the LBDs can be thought of as existing in 
various “states”, states that depend on the ligand’s structure and function at different 
NNRs.  Further, when all five LBDs are occupied by the same ligand in a crystal 
structure, or when only some but not all of the LBDs are occupied, additional information 
on differences from one LBD to another may be examined.  Therefore, these occupied 
LBDs may be compared to unoccupied LBDs in either the same crystal structure or the 
apo form5 to provide data on the effect of various agonists and antagonists on the LBD 
geometry.  These data may provide useful information of use for the development of 
homology models for the NNRs. 
A number of features play critical roles for ligand binding in the AChBPs.  These 
include the B-loop and  the C-loop (containing a sulfur-sulfur bond in adjacent cysteine-
cysteine residues) from one subunit , and the F-Loop from another subunit( Figure 3 ).5  
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The LBDs for all AChBPs (and NNRs) are composed of the C-Loop from one 
face (called the principal face) and the residues that come in contact with the C-loop on 
the adjacent face (called the complementary face).5 Ligands co-crystallized with the 
AChBPs represent considerable diversity in shape and size, with the crystallographic 
data showing significant variance in the LBD depending on the ligand co-crystallized.   
For example, the C-Loop can move as much as 11 Å depending on the ligand that is 
bound. It moves 7.3 Å inward from the apo5 form when a small agonist like epibatidine 
binds and 4.3 Å outward from the apo form to open up for interaction with the peptide 
antagonist α-connotoxin.5   
 
Figure 3. Nicotinic 
Receptor  and Apo 
AChBP Monomer 
Comparison . Similar to 
image in  Hansen, S. 
B.;et al.. The Embo 
Journal. 2005, 24, 3635-
3646.  One subunit of 
the apo AChBP (blue) 
superimposed on one 
subunit of the torpedo 
(red) structure. Loops 
that participated in 
ligand binding are 
named. 
 
 
 
The Aplysia californica
from the agonists epibatidine and lobeline to the antagonists methyllycaconitine and the 
small peptide, α-connotoxin.
structures  with two agonists, nicotine and carbamylcholine
large movements in the C
near the C-terminal transmembrane
NNRs mimic the molecular motions observed by AChBPs which may lead to channel 
gating.5 Receptor structural data also comes from a cryoelectron micrograph of 
mamorata and the α1 face of a mouse muscle NNR.
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 AChBP has been co-crystallized with a variety of ligands 
5 For AChBP from  Lymnaea stagnalis
4 have been published.  The 
-loop result in small changes of less than 2 Å of
 region.5 Hansen and colleagues propose that the 
3,2  
Figure 4. C-Loop Movement. Similar to part of 
an image in Hansen, S. B.;et al. The Embo 
Journal. 2005, 24, 3635-3646.  Shows 
representative movements of the “top” of the 
Loop in comparisons of  epibatidine AChBP 
(blue), the apo form of A-AChBP (green) and the 
a-connotoxin A-AChBP (red) structures. 
, two co-crystal 
 other loops 
Torpedo 
 C-
 
 Careful analysis of the nicotine, carbamylcholine and hepes co
reveal that the cationic center of the
above tryptophan 143 (W143 in the Lymnaea structure and W147 in the Aplysia AChBP) 
forming a cation-π interaction. Tryptophan 
interaction of all the naturally occurri
propose that electrostatic and steric interactions control the stability of the ligand
complex in ACHBP, and that the cation
NNR activity.17  For NNRs, it
acetylcholine to bind through a cation
electron rich aromatic side chains of the LBD.
Figure 5. Ligands co-crystallized with 
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-crystal structures 
 protonated or quaternary amine 
displays the strongest 
ng aromatic amino acids.16 Artali and colleagues 
-π interaction is most important, especially for 
 is also expected that the endogenous neurotransmitter, 
-π interaction with its quaternary amine and the 
17  
Aplysia AChBP. Figure 6. Ligands co-crystallized with 
Lymnaea AChBP. 
 
ligand is located 
cation-π binding 
-protein 
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 To better understand the effects of ligand binding on the relative geometry of 
residues located in the LBD, I undertook a careful analysis of both intra- and inter-
variations in structure for the L- and A-AChBPs that have been co-crystallized with NNR 
ligands.  Further, examined the ability of several docking algorithms to reproduce the 
known poses (based on crystallographic data) of co-crystallized NNR ligands, and the 
ability of scoring functions to accurately reproduce ligand binding affinities for a divers 
set of NNR ligands. 
 
 
Figure 7.  Apo AChBP and NNR 
Pentamer Comparison. Similar 
to image in Brejc, K.; et. al. 
Nature. 2001, 411, 269-276, 
Unwin, N. J. Mol. Biol. 2005, 
346, 967-989. Not that the 
AChBP structure is very 
similar to the extracellular 
domain of the NNR. 
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CHAPTER II 
INTRODUCTION 
Hypotheses 
 Geometric analysis of the five LBDs in AChBPs should provide data on the 
extent of vaience from one LBD to another within a single protein while analysis of 
different co-crystal structures as well as the apo form should provide information on 
those changes that occur as a result of ligand binding. The five LBDs in a single protein 
are expected to be quite similar, while dramatic differences are expected for different 
ligands, as well as the apo5 form. A more complete understanding of the LBDs and 
changes that occur after ligand binding will provide a better understanding of how 
various ligands interact with LBD residues, and should provide a basis for the 
development of better homology models of NNRs. 
 CDOCKER and Glide 4.5 (standard precision and extra precision) docking 
algorithms should reproduce the crystal structure pose for the ligands that are co-
crystallized, and their scoring functions should rank order the poses in terms of RMSD 
(the pose that is closest to the co-crystal structure pose should have one of the best 
scores). Therefore a correlation between the scores and RMSD should exist. However, 
since the NNR ligands bind through a cation-π interaction17 and the scoring functions for 
CDOCKER and Glide 4.5 (standard precision and extra precision) do not reward this 
type of interaction, the scoring functions do not correlate with the RMSD. The 
information from these experiments will be used to pick a few proteins and a single 
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method to run docking studies on a variety of NNR ligands with known Kd values to 
examine the correlation between Kd values and scores for various poses. 
Goals 
Ultimately, data collected during this project will help guide development of homology 
models for various NNR subtypes, based on a more complete understanding of 
AChBPs.  These homology models may then be used to guide drug discovery efforts. To 
achieve this goal, the following tasks will be undertaken: 
1. The AChBPs LBD for the different ligands that have been co-crystallized will be 
geometrically analyzed. 
2.  Several different docking tools and scoring functions will be explored using the 
nicotine (nic),4 carbamylcholine (cce),4 apo,5 epibatidine (epi),5 methyllycaconitine 
(mla)5 and lobeline (lob)5 crystal structures as docking structures. A scoring 
function will be sought that correlates with known AChBP experimental binding 
data (Kd).  
3. Determine which of the co-crystal structure AChBPs provides the lowest RMSD  
for docked NNR compounds and which docking tool show most promise in 
reproducing either the RMSD and/or correlates best with docking scores. 
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CHAPTER III 
PROCEDURES 
Aim 1. AChBP Geometrical Analysis Using Maestro V 7 .5 
(Schrodinger, Inc.) and Discovery Studio 2.0 (Accel rys) 
Protein Structural Data: PDB codes for Aplysia AChBP are 2BYN (APO), 2BYR 
(MLA co-crystal structure) 2BYS (LOB co-crystal structure )and 2BYQ  (EPI co-crystal 
structure).5 PDB codes for Lymnaea AChBP are 1UV6 (CCE co-crystal structure) and 
1UW6 (nicotine co-crystal structure).4 
Protein Sequence Analysis:  To illustrate the similarities and differences both 
across the three AChBP proteins, and their similarities and differences to the NNR 
extracellular regions, sequence alignment of A-, L- and B-AChBP with human 
α4, β2, and α7 subtypes were carried out. This was done using Clustal W multiple 
sequence alignment which is available through Biology workbench version 3.2 offered by 
the SDSC (San Diego Supercomputer Center). All the default settings were used. This 
sequence alignment was done in order to compare the three AChBP structures with both 
human and rat α3-α7 and β2-β4. The alignments for some of the subtypes were 
removed for clarity. 
Geometric Protein Analysis:  To better characterize the subtle differences that 
exist both within crystal structures of the various AChBP structures and across the 
various co-crystal structures, centroids were defined for all key residues in the LBD.  
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Measurements were taken for distances from the centroid of the binding site residues to 
each other (including the ring formed by C190 and C191) from different co-crystal 
structures. These distances were measured for each of the five potential binding sites, 
using Maestro 7.5 and then the average and standard deviation values for each distance  
were calculated and graphed relative to the apo form5.  This provides a snapshot of both 
consistency within a structure and variation across structures for various geometric 
features that help define the pharmacophoric recognition feature of the LBD. In addition, 
angles (defined to illustrate key features in the LBD) were also measured for each 
binding site, as were Chi1 and Chi2 parameters for each aromatic residue. The Chi1 and 
Chi2 parameters were measured using the MOE program from Chemical Computing 
Group. Averages and standard deviations were calculated for each angle and graphed. 
In this case the angles were not relative to the apo form. Since each LBD is formed 
through interactions of two subunits, pharmacophoric distances were measured between 
I118 and W147 to indicate the movement of each subunit relative to each other. This 
distance was measured using Discovery Studio 2.0 from Accelrys. 
Ligand-Protein Analysis:  Analyses were performed to determine changes that 
occur when both agonists and antagonists bind to the AChBP. Distances from the 
cationic center to the centroid of the aromatic rings of the binding site were measured for 
several co-crystal structures. Angles and torsions were also measured. As a visual 
indicator of variance, distances were plotted on one graph while angles and torsions 
were plotted on separate graphs. The angles measured were: 
• Cationic center  W147 centroid  the N of the indole ring on W147; this angle 
provides a measure of the relative alignment of the ligand cationic center to the 
conserved tryptophan.  
 
14 
 
o For L-AChBP structures, cationic centerW55centroidthe N of the 
indole ring on W55.  For A-AChBP, W55 is replaced by tyrosine.  In the 
latter case, the carbon atom of the tyrosine ring closest to the indole N 
from W55 was used, with that atom determined by superimposition of the 
lymnaea and aplysia structures using backbone atoms.  This angle 
provides an indication of movement of the complementary face relative to 
the principal face. 
In order to determine the position of the ligand in the binding site relative to the 
conserved tryptophan (W147), two torsion angles were measured: 
• W147 indole ring NW147centroidcationic centerW147 backbone carbonyl 
• W147 indole ring NW147centroidcationic centerligand hydrogen bond 
acceptor 
Ligand protein analyses were carried out on all 5 of the binding sites in the epibatidine 
(A-AChBP) and nicotine (L-AChBP) co-crystal structures in order to measure variation 
from one LBD to the next. 
Aim 2. AChBP Docking Studies 
Hansen et al.5 have observed that each ligand co-crystalized with an AChBP 
induces local conformational changes. Further, the C-loop acts as an “induced-fit 
sensor” which effectively molds itself around the ligand during binding.  Based on these 
observations, studies were undertaken to dock co-crystal structure ligands both back 
into their complimentary LBD, but also into the LBDs of other AChBPs (both from aplysia 
and lymenaea). These studies were designed to assess how sensitive docking algoritms 
might be to these local changes.  Further, there was the question of templates for 
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binding studies – was one structure more likely than another to serve as a satisfactory 
starting point for correlation with binding affinity values. 
 Structures selected for these studies are shown in Table 1 along with binding 
affinity values for L-AChBP and/or A-AChBP.  Kd values are taken from the literature or 
from private communications from Dr. Todd T. Talley, University of California, San 
Diego. 
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aTaken from 18 Talley, T.; Yalda, S.; Ho, K.; Tor, Y.; Soti, F.; Kem, W.; Taylor, P., Spectroscopic analysis of 
benzylidene anabaseine complexes with acetylcholine binding proteins as models for ligand-nicotinic 
receptor interactions. Biochemistry 2006, 45 (29), 8894-902. 
b Taken from 2, 4 Celie, P.; van Rossum-Fikkert, S.; van Dijk, W.; Brejc, K.; Smit, A.; Sixma, T., Nicotine and 
carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 
2004, 41 (6), 907-14. 
c Taken from 2, 19 Taylor, P.; Talley, T.; Radic', Z.; Hansen, S.; Hibbs, R.; Shi, J., Structure-guided drug 
design: conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypes. 
Biochem Pharmacol 2007, 74 (8), 1164-71. 
d Private communication from Dr. Todd T. Talley, UCSD. 
Table 1. NNR Ligand Dataset.  Name, structure and Kd values for both Lynmaea and Aplysia AChBPs. 
The two sterioisomers of nicotine and TI-1 were docked because both bind to the receptor. 
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  Using the crystallographic coordinates as starting points, each co-crystal 
structure ligand was protonated and then minimized to the local minimum conformation 
using the Jaguar default settings (Schrodinger, Inc). Each minimized ligand was then 
docked into the Nic,4 Cce,4 Apo,5 Epi,5 Mla,5 and Lob AChBP5 crystal structure (with and 
without) a water of crystallization. Docking into the various L and A-AChBP protein 
structures (after removal of bound ligand) for proteins without water of crystalliztion was 
carried out using CDOCKER and Glide (4.5). A minimum of 10 poses were saved for 
each ligand. An RMSD value for each saved pose was then calculated by comparison to 
the original co-crystal structure ligand pose. This provides a measure of the ability of the 
program to reproduce the experimental pose in the LBD. To assess the ability of each 
program’s scoring function to accurately rank order various poses compared to the 
experimental pose for each ligand, the score vs. the RMSD were plotted and correlation 
coefficients (R2) were calculated using Microsoft Excel.17  
 Low energy conformations for each ligand were also docked into various 
AChBPs, but with an explicit water to provide the possibility for water-mediated hydrogen 
bonding between the putative hydrogen-bond acceptor of each ligand, and the backbone 
of the protein in the LBD.  These studies were only carried out using CDOCKER and 
Glide v 4.5. A minimum of 20 poses were saved and the RMSD was again calculated for 
each pose referenced to the crystal structure pose. The water molecule chosen was the 
one that mediates the hydrogen bond from the nicotine pyridine ring to Met 114 in the 
Lymnaea crystal structure. All the other AChBPs were superimposed with the Nic 
AChBP by sequence alignment and the water molecule from the Nic AChBP was copied 
to the other AChBPs.  
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For all docking studies, the binding site residues and the water molecule were 
selected to generate the grid and the sphere for docking the compounds with Glide v 4.5 
and CDOCKER.  Glide docking studies were carried out at both Standard and Extra 
Precision levels. 
A second set of docking experiments were performed with 19 NNR ligands 
(represented as individual compounds, diasteriomers based on variation in protonation 
of tertiary amines or differing starting conformations) using the Standard Precision 
algorithm available from Glide v 5.0. Several of these ligands were those co-crystallized 
with either Lymnaea stagnalis or Aplysia californica AChBP).  Low energy conformations 
for all ligands (as the protonated species where appropriate) were generated using 
either Sibyl (Tripos, Inc.), Mopac AM1 or Jaguar (Schrodinger, Inc.). 
Ligands were docked into protein structures representing both species (A-apo5, 
A-hepes,20 A-epi,5 A-lob,5 L-hepes13 and L-nic4) where the co-crystal ligand had been 
removed.  For each docking study, a maximum of 20 poses was saved for each ligand.  
Using a perl script developed for this purpose, each asset of poses was analyzed 
(Pipeline Pilot, Accelrys, Inc.) via a protocol that ranked the poses for each ligand, based 
on similarity to known geometric parameters derived under Aim 1. Pharmacophoric 
distances and angles were measured for each pose for all ligands, using the same 
metrics as those measured in the ligand-protein geometrical analyses. Poses were 
sorted based on cation-π distance and indole N to I118 or M114 amide N depending on 
if the protein, i.e., from aplysia or lymnaea, respectively. RMSD values were calculated 
for each ligand when co-crystal structures were available. The protein was frozen in 
every docking study, with only the ligand allowed to move. 
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Aim 3. Scoring Functions 
 Where binding data were available, the Glide scoring function and the scoring 
functions implemented in CDOCKER were used to investigate the correlation between 
scoring function and Kd binding affinity values to L-AChBP and A-AChBP for each of 
these NNR ligands. The Score Ligand Poses protocol available from Accelrys Discovery 
Studio 2.1 was also utilized to score poses for ligands docked into each AChBP from 
both sets of docking jobs. Correlation between the best scoring pose for each ligand and 
the pKd (-log(Kd)) was calculated for each protein-ligand docking set.
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CHAPTER IV 
RESULTS 
AChBP Geometrical Analysis 
 
 
 
Figure 8. Ligand binding domain residues. 
 
21 
 
Figure 8 shows key residues in the LBD for which pharmacophoric distances and 
angles were measured. Figure 9 summarizes results for both intra and inter-protein 
structure comparisons of various distances in co-crystal LBDs.  For example, Fig 9a 
shows the average distance (and standard deviation) between W147 and the centroid 
defined by the ring (defined from the α carbon to the sulfur for each cysteine residue) for 
C190-C191for the occupied and unoccupied LBDs. Measures were taken and compared 
for the co-crystal structures for IMI-,5 EPI-,5 MLA-,5 HEPES-,20 LOB-A-AChBP5 as well as 
the average distances and standard deviation for NIC- and CCh-L-AChBP,4 and CAPS-
B-AChBP.14 In all cases, distances are relative to the APO-A-AChBP.5 
  As noted by Hansen, residues on the C-Loop (C190, C191, Y188 and Y195) 
move closer to W147 compared to the apo5  structure for the smaller ligands, and stay in 
similar positions (MLA) or move further away for the largest ligand, i.e., IMI, see  Figs. 
9a, 9b and 9e. Further, the distance between the two residues Y195 on the principal 
face and Y55 on the complementary face differ with each ligand, (Fig 9f) indicating a 
breathing motion for the side-to-side dimensions of the LBD. This analysis, however, 
shows a greater level of detail than has been provided previously.  For example, one 
notes that the distance given by the W147-to-C190, 191 centroids shows relatively little 
variation within a protein from one LBD to another, and similar average differences from 
one co-crystal structure to another for all of the small ligands, even cross species, i.e., A- 
to L- to B-AChBP. Further, ligand binding in all cases cause a small expansion of the 
relative distance from W147 (principal face) to Y55 (or W55) on the complimentary face 
(Fig 9c).  Also, it should be noted that movements of the C-loop, brought on by binding, 
are asymmetrical, with Y195 moving towards W147 to a much lesser extent (about 2 Å, 
see fig 9e) compared to the much larger movement of Y188 (Fig. 9b).  As noted by 
 
Hansen, lobeline stands out compared to the other small ligands in that binding causes 
an opening of the side-to
Y93 distance, compared to contraction of that distance 
even large ligand cases, see Fig 9d).
 
Figure 9. Binding  Site Distances Measured
Figure 25, for definitions of measured distances.
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-side distance as evidenced by the expansion of the W147 to 
in all other small ligands 
 
. All distances are relative to the Apo form.
 
(and 
 
 See Appendix A, 
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Fig 10 shows atoms used to define the Chi1 and Chi2 angles. Fig 11 demonstrates that 
Chi1 varies little compared to the Apo5 form for all co-crystal structures analyzed with 
two exceptions. Y55, which varies with each ligand since this residue comes from the 
complementary face; and, Y93, which is close to trans for lobeline where this residue 
has moved out of the way to provide additional space for one of lobeline’s phenyl 
groups.  
 
 
Figure 10. Definition of Chi1 and Chi2 angles.  
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As indicated by Figure 12, Chi2 tends to vary for each ligand such that the protein 
adjustes to accommodate the ligand. Further, one may note that in the case of the 5 
LBDs for the HEPES structure, there is relatively little change for the occupied LBDs 
Hepes Occ) compared to those that are unoccupied (Hepes Unocc) by this weakly 
bound ligand. The standard deviations calculated for the distances, chi1 and chi2 angles 
of the proteins indicate that all the binding sites are indeed structurally similar with few 
exceptions (hepes and lob). 
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Figure 11.   Chi 1 Angles. Chi 1 angles as defined in Fig. 10; angles are not relative to the Apo form. 
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Figure 13 shows that distances from the ligand cationic center to the aromatic 
residue centroids of the LBD vary by as little as 1 Å to as much as 3 Å for all ligands 
analyzed. The torsions and angles vary by 20 to 50 degrees from the smallest to the 
largest angles for all of the ligands analyzed (Figure 14). These data will provide useful 
guidelines to sort out poses for each ligand during docking studies. Only those poses 
that fall within the normal distance and angle ranges will be analyzed. 
Figure 12. Chi 2 Angles. Chi 2 angles as defined in Fig 10; these are not relative to the Apo Form. 
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Figure 14. Angles from the Ligand Cationic Center to Binding S ite Residues  Angles  
and torsions measured for Epi, Lob, Nic, Cce, Coc, L-hepes (L-EPE) and A-hepes (A-Epe). 
 
           
 
 
 
Figure 13.  Distances from the Ligand Cationic Center to Bindin g Site Residues . 
Distances from the ligands cationic center to the centroid of the aromatic residues in the LBD.  
Measured for Epi, Lob, Nic, Cce, Coc, L-hepes (L-EPE) and A-hepes (A-Epe). 
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Table 2 provides a detailed ligand-protein analysis for distances, angles and 
torsion angles for each of the five LBDs for the EPI-A-AChBP and NIC-L-AChBP co-
crystal structures. Torsion angles, plane angles and distances were measured using the 
cationic center of each bound ligand to the aromatic residues for each binding site of the 
epibatidine and nicotine co-crystal structures.  Distances from the cationic  nitrogen to 
the centroid for W147, as well as the cationic nitrogen and the centroid for Y93 are 
significantly different for the epibatidine co-crystal structures when compared to the 
nicotine co-crystal structures at the p = 0.05 level, indicating a closer movement of the 
epibatidine ligands to the aromatic residues compared to that for nicotine. This is of 
interest since epibatidine binds with substantially higher affinity at both A- and L-AChBP, 
indicating that epibatidine is utilizing more efficiently LBD interactions than does nicotine. 
The cationic center to Y188, cationic center to Y195 and the cationic center to Y55 
distances are all equivalent in all the LBDs across these two proteins. 
Additional distance and angle measurements were taken for the distance from 
W147 indole N to I118 amide N and the angle from W147 indole N to I118 carbonyl O to 
I118 carbonyl C.   These measurements were taken to assess the relative movement of 
the two subunits which form the LBD. These data, for torsions, angles, and distances 
measured for one ligand binding domain from each co-crystal structure, suggest that the 
protein undergoes a conformational change upon ligand binding and the changes are 
specific to the shape and size of the ligands. 
 
 
 
 
 
 
 
 
28 
 
W147/143 Y188/185 Y195/192 Y93/89 Y55/W52 W147/143 W147/143 W147/143 Y55/W53
N+ to 
W147 Cen
N+ to 
Y188 Cen
N+ to 
Y195 Cen
N+ to 
Y93 Cen
N+ to Y55 
Cen
N+ to 
W147 Cen 
to N
N to W147 
Cen to N+ 
to O
N to W147 
Cen to N+ 
to HA
N+ to Y55 
Cen to N
Ligand  Distance Distance Distance Distance Distance Angle
Torsion 
Angle
Torsion 
Angle
Angle
epi 
(AE)
3.27 5.71 5.55 5.04 6.35 108.00 -34.98 -0.17 92.39
epi 
(ED)
3.19 5.48 5.96 5.11 5.62 107.70 -43.66 8.47 94.79
epi 
(DC)
3.77 5.50 5.51 4.87 6.12 115.50 -34.53 1.81 91.49
epi 
(CB)
3.73 5.20 5.20 4.84 6.36 109.00 -31.35 -2.62 101.67
epi 
(BA)*
4.11 5.36 4.50 5.06 7.13 96.50 -27.86 -1.04 102.68
nic 
(AB)
4.07 5.54 4.92 5.76 6.54 94.20 -34.27 -172.99 111.51
nic 
(BC)
4.42 5.08 4.49 5.87 6.80 96.10 -31.45 177.21 111.56
nic 
(CD)
4.14 5.49 4.84 5.76 6.46 95.40 -35.01 -176.11 112.38
nic 
(DE)
4.30 5.43 4.66 5.95 6.67 96.50 -32.67 -173.47 112.10
nic 
(EA)
4.21 5.37 4.62 5.86 6.34 99.50 -35.20 -177.34 110.81
*structure w/ pyridine ring rotated 180o
 W is numbered 147 in the Aplysia AChBP  and is 143 in Lymnaea AChBP
 
 
 
 
Table 2. W147 to I118 Measurements. Distance, angle and Torsion angle measurements for all 5 different 
LBDs for nic and epi co-crystal structures. N+—Cationic Center, Cen—ring centroid, N—W indole ring, O—
W carbonyl O, and HA—hydrogen bond acceptor. 
Figure 15. Complementary Face 
Changes Relative to the 
Principal Face. Apo, lobeline and 
epibatdine structure 
superimposed on W147. Shows 
the movement in  I118 from the 
complementary face suggesting 
that the complementary face 
adjusts to the ligand. Pink—
lobeline, Green—epibatidine, and 
Gray—Apo. 
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The distance measurements indicate that the two subunits that make up the binding 
domain in the Aplysia-lobeline co-crystal structure move further apart from each other 
when compared to the apo and epibatidine structures,5 Figures 16, 17a and 17b. 
(Lobeline binding seems to push the two subunits apart). In addition to the subunits 
moving apart, lateral movements of the two subunits with respect to each other were 
also observed. W147 to I118 carbonyl O to I118 carbonyl C illustrated that the 
epibatidine structure had the greatest angle. This large angle indicates that the α-C has 
shifted laterally but the hydrogen bonding interaction between the indole N-H of W147 
and the carbonyl O of I118 kept carbonyl O of the residue in place and moved the rest of 
the residue, which causes the I118 carbonyl group in the epibatidine structure to form an 
angle such that, when overlapped the carbonyl bond of the epibatidine structure 
intersects with the carbonyl bond of the apo form. However, the lobeline structure I118 
carbonyl group only intersects with the apo form at the carbonyl O. 
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Figure 17. Distances Between the Prinicpal and Complementary F aces Averaged. Part a shows the 
average distances between W147 indole nitrogen and I118 amide nitrogen with error bars. Part b shows the 
averages relative to the apo form with error bars. 
Figure 16. Distances Between the P rinicpal and Complementary Faces.  All of the distances measured 
were co-crystallized with Aplysia, except for nicotine, which was crystallized in Lymnaea. 
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AChBP Docking Studies 
Docking Analysis with crystal structure ligands 
Docking Without Water  
Docking studies were carried out on all ligands where published co-crystal 
structures with either A- or L-AChBP are available. As noted previously, attempts were 
made to reproduce representative crystal structure poses, both in the presence and 
absence of a molecule of water, present in many co-crystal structures in the HBA region 
of the ligands. Docking analysis without the water of crystallization indicated that the 
epibatidine crystal structure pose was reproduced when docked into in most of the 
AChBPs except for the MLA structure, using CDOCKER or Glide SP and XP. However, 
the lobeline and imidacloprid crystal structure poses were only reproduced in the 
lobeline AChBP. As for nicotine, the crystal structure pose was only reproduced in the 
lob, epi, and nic AChBPs using all the methods tested. Glide SP and XP docking 
algorithms were able to reproduce the crystal structure pose for nicotine in the cce,4and 
apo5 structure as shown by the RMSD. Interestingly none of the docking algorithms 
reproduced the crystal structure poses for any of the ligands in the MLA AChBP. 
Unfortunately, there was no correlation with any of the scoring function scores and the 
root mean square deviation (RMSD) of the poses to the crystal structure pose. 
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Docking With Water of Crystalliztion 
Docking the low energy crystal structure ligands with inclusion of a molecule of 
water (taken from the nicotine co-crystal structure in the HBA region) helped to improve 
the reproducibility of the crystal structure poses for most of the ligands except for 
lobeline. For example, epibatidine and nicotine crystal structure poses were reproduced 
in most of the AChBPs tested using CDOCKER and Glide SP and XP, except in a few 
cases. On the other hand, the lobeline crystal structure pose was only found when 
Table 3. Crystal Structure Ligands Docked Without  Explicit Water.  Lowest RMSD (Å) for the poses 
docked without water of crystallization using Glide (SP and XP) and CDOCKER, compared to the co-crystal 
structure for that same ligand. 
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docking occurred into the lobeline crystal structure, for all three docking methods. As for 
imidacloprid, the explicit water did help the docking methods reproduce the crystal 
structure pose in more of the AChBPs. In conclusion, while a water of crystallization 
does improve the accuracy of the docking algorithms, scoring functions still do not 
correlate well with the RMSD values. There did appear to be a trend towards better 
correlation of the Glide GScore to experimentally determined Kd values than that found 
for the CDOCKER score, but the data set is too small to judge.  RMSDs to prove how 
close the docked pose is to the crystal structure are needed here. 
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Docking Analysis with 19 NNR ligands. 
 Docking studies were carried out on a diverse set of 19 NNR ligands for which 
Kd data are available, docked with a water of crystallization.  Analysis of the resulting 
docked poses and docking scores indicated that an H-bond term for water-ligand HBA 
was not reflected in the score. Careful observation of the poses with the explicit water 
molecule showed that the orientation of the hydrogen atoms on the explicit water 
molecule were rotated so that it no longer held the conformation that would let it 
Table 4. Crystal Structure Ligands Docked With Explicit Wate r. Lowest RMSD (Å) for the poses docked 
with water of crystallization using Glide (SP and XP) and CDOCKER. 
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hydrogen bond to the ligand and I118 or M114 depending on the crystal structure 
species used. Therefore, all of the data for the docking studies with water will be 
excluded from the following discussions.  Data for the docking studies without water 
were analyzed and are presented in Figures 16 to 20. 
 It is of note that careful analysis of the lobeline and nicotine co-crystal structures 
shows that the explicit water in the lobeline structure was shifted closer to I118 than it 
was to M114 in the nicotine structure. An explanation for this observation is that the 
lobeline structure is wider than the nicotine structure, so when lobeline binds, the 
hydrogen bond acceptor ends up closer to I118 and, pushes the explicit water molecule 
closer to I118.   Thus, we now have good evidence for the importance of a water in the 
HBA region, and the likelihood that the water adjusts for each ligand.to optimize the 
hydrogen bond donor-hydrogen bond acceptor interaction. 
As a result of the docking studies without water, the AChBP structures that have 
been co-crystallized with smaller ligands, such as the nicotine, epibatidine, aplysia 
hepes and lymnaea hepes, have a tighter ligand binding domain than the lobeline and 
apo5 AChBP structures. Therefore, the limitation in using a docking tool that keeps the 
protein frozen is that bulkier ligands such as lobeline and DMXBA cannot fit into the 
ligand binding domain of one of the tighter AChBP structures. So, the Nic, Epi, A-Epe, 
and L-Epe structures were analyzed only for the ligands that were docked into the 
binding site.  
Based on our earlier geometrical analyses, Glide 5.0 was able to find the 
“expected pose” for each ligand that was docked. However, the “expected pose” was not 
always the best scored pose. Therefore the “expected pose” was determined by: (1) 
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using the range of 3-5.5 Å for the distance between the cationic center and the centroid 
of the indole ring on W147. This served as a filter to eliminate poses in which the 
cationic center is too far away from the indole ring of W147 to from the expected cation-π 
interaction; (2) using the range of 3.5 to 6.5 Å for the distance between the hydrogen 
bond acceptor on the ligand and the indole ring N on W147. This served to filter out 
poses with the hydrogen bond acceptor in a region that was very different from that 
observed in known crystal structures; and (3) using the crystal structures as guides, the 
poses that were not eliminated, were carefully observed for the orientation of the cationic 
center and the hydrogen bond acceptor in order to identify that orientation closest to the 
crystal structures. In the case where more than one pose appeared to be the “expected 
pose”, the pose with the lowest (more negative) Gscore was selected as the “expected 
pose”.   
Since the Kd data were obtained from different labs and by different techniques, 
variations in Kd values can be expected. The Kd values that were obtained in Palmer 
Taylor’s lab at UCSD were determined by measuring the displacement of tritiated 
epibatidine by the ligand being tested. However, some of the data from the Taylor 2007 
review article19 were taken from other sources. The Kd values for epibatidine, lobeline, 
methyllycaconitine and α-conotoxin5 were determined using the ratio of dissociation to 
association rates by monitoring intrinsic tryptophan quenching with stopped flow 
spectrofluorometry. In order to simplify the data for graphing, Kd values were converted 
to the pKd (pKd = log(1/Kd)).  A higher pKd value indicates that the ligand shows higher 
binding affinity. 
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The glide scoring function, called the Gscore,21 assigns the poses a score based 
on the interaction energies between the posed ligand and the protein. The equation 
Schrodinger released for the Gscore is as follows: 
Gscore = a* vdW + b * Coul + Lipo + Hbond + Metal + Rewards + RotB + Site 
 a = 0.050, b = 0.150 for Glide 5.0 
 vdW = van der Waals interaction energy 
 Coul = Coulomb interaction energy 
 Lipo  = Lipophilic-contact plus phobic-attractive term 
 HBond = Hydrogen-bonding term 
 Metal  = Metal-binding term (usually a reward) 
 Rewards = Various reward or penalty terms 
 RotB  = Penalty for freezing rotatable bonds 
 Site = Polar interactions in the active site 
 (GScore = 10000.0 indicates that a given ligand pose failed one or more criteria 
for computing GScore.  Depending on which ones it failed, the components of 
GScore may not be valid either.) 
 
The more negative Gscore reflect better interaction between the ligand and the protein. 
However, as revealed below, the best Gscore was not assigned to the compound with 
the highest pKd. It is possibly that this occurs because the Gscore equation does not 
have a term for the cation-π interaction, an interaction believed to drive ligand binding in 
the NNRs.  
 Based on the information that poses assigned a more negative Gscore have a 
better score and the larger the pKd value imply better binding affinity, if a correlation 
exists between the Gscore and the pKd, the trend line (in a plot of Gscore vs. pKd) 
should have a negative slope. The negative slope implies that ligands with lower binding 
affinity (poorer pKd values) should be assigned a more positive Gscore and ligands with 
higher binding affinity (more positive pKd values) should get a more negative Gscore. In 
the results discussed below, the degree of correlation of these two quantities was 
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evaluated using the R2 value resulting from a linear least squares fit of the data. Docking 
experiments that yielded a higher R2 were deemed the better results. An R2 value of 
about 0.8 is expected for the docking study.17 In general, all of the correlations observed 
between the Gscore and the pKd were very low.  As discussed below, in comparisons of 
the data from each AChBP structure the lobeline AChBP structure was found to have a 
better correlation between the pKd and the Gscore than other AChBP structures studied.
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DOCKING STUDIES
Apo5 AChBP Structure
 Glide 
dock 14 out of the 19 ligands 
from the dataset 
into the aplysia 
structure. 
illustrates a plot of the 
“expected pose” Gscore vs. 
the pKd. No correlation was 
observed because the data is 
too scattered, the R
Figure 18b shows the best 
Gscore and the pK
correlation was observed 
either (R2 = 0.0
Figure 18. Docking Results for Ac
Apo Without Explicit Water.
shows the correlation between the 
Gscore and pKd. Part a shows the 
correlation between the Gscore for the 
expected pose for each ligand docked. 
Part b shows the best Gscore versus 
the pKd, while Part c) shows the graph 
of the difference between the best 
Gscore and the expected pose Gscore 
versus the pKd. The pK
calculated by taking the log of (1/K
with the Kd expressed in nanomolar 
units. 
 
: Aplysia 
 
5.0 managed to 
(see Table 1) 
apo5 AChBP 
Figure 18a 
2 = 0.002. 
d. No 
here 
40). After no 
-
 The data 
d values were 
d) 
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correlation was observed in Figures 18a and b, the difference between the best Gscore 
and the “expected pose” Gscore was graphed (Figure 18c). No correlation was observed 
from this graph as well (R2 = 0.010).   The C-Loop conformation in the Apo5 form may 
affect the correlation as it does not optimize interactions with the ligands. Therefore the 
Apo structure may not be the best template from which to construct a homology model 
useful for docking NNR ligands.  
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DOCKING STUDIES: Aplysia 
Hepes AChBP Structure
 The aplysia hepes 
structure was more difficult to 
dock ligands into. Glide
was able to dock only 7 of the 
19 ligands from the dataset. 
The “expected pose” Gscore 
vs. the pKd is plotted in Figure 
19a. The correlation 
coefficient for Figure 19a (R
0.075) showed a slight 
improvement but was still very 
low. The slope of the trend
of the aplysia hepes graph
(figure 19a) is more negative 
Figure 19. Docking
Epe Without Explicit Water
shows the correlation between the 
Gscore and pK
correlation between the Gscore for the 
expected pose for each ligand docked. 
b) shows the best Gscore versus the 
pKd, and c) shows the graph of the 
difference between the best Gscore 
and the expected pose Gscore versus 
the pKd. The pK
calculated by taking the log of (1/K
with the Kd expressed in nanomolar 
units. 
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than the slope of the trend line from the aplysia apo5 graph (figure 18a) implying that the 
Aplysia hepes structure may be a slightly better template for a NNR homology model. 
Figure 19b shows the graph of the best pose Gscore vs. the pKd. Again, correlation for 
docking into aplysia hepes (Figure 19b) seems to be slightly better when compared to 
that for docking to the apo structure (Figure 18b).  Again, the trend line has a slightly 
more negative slope than that found for aplysia apo5. Figure 19c demonstrates a scatter 
plot of the difference between the “expected pose” Gscore and the best pose Gscore vs. 
pKd. Comparing figure 19c to figure 18c, one can conclude that the trend line in figure 
19c actually has a more negative slope than that of figure 18c. While docking to the 
aplysia hepes AChBP structure displays a slightly higher correlation between the Gscore 
and pKd values, Glide 5.0 was only able to dock 7 out of the 19 NNR ligands into this 
structure, so while better than the aplysia Apo structure, it is still not a very good 
template. 
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DOCKING STUDIES: 
Aplysia Lobeline AChBP 
Structure 
 Glide 5.0 was able to 
dock 10 out of the 19 NNR 
ligands into the aplysia 
lobeline structure.
correlation was 
between pK
“expected pose” Gscore 
(Figure 20a) and the best 
Gscore (figure 20b)
values are 0.305 and 0.383 
respectively. Figure 20c 
illustrates a scatter plot of
Figure 20. Docking Results for Ac
Lob Without Explicit Water.
data shows the correlation between 
the Gscore and 
the correlation between the Gscore 
for the expected pose for each 
ligand docked. b) 
Gscore versus the 
shows the graph of the difference 
between the best Gscore and the 
expected pose Gscore versus the 
pKd. The pKd values were calculated 
by taking the log of (1/K
expressed in nanomolar units
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the difference between the “expected pose” Gscore and the best pose Gscore vs. pKd. 
Figure 20c shows that the varience in the error (predicted vs actual) between these two 
measures is essentially evenly distributed. Comparison of figures 18a, 18b, 19a, 19b, 
20a and 20b suggests that the lobeline AChBP structure (figures 20a and 20b) would be 
the best template for NNR homology modeling because these graphs show the best 
correlation between the pKd and the Gscore and these graphs have a trend line with the 
most negative slope. The conclusion drawn from this data is that the lobeline structure is 
the best template for NNR homology modeling.  
 However, the data in figure 20a and 20b may be skewed by the lobeline point, 
which falls in the lower right hand corner of the graph, while the rest of the data is 
clustered together in the middle of the graph. The possibility exists that the correlation 
observed in figures 20a and 20b could be a “pseudo-correlation.” Glide 5.0 assigned the 
lobeline point the best (most negative) score and lobeline had the best (highest) pKd of 
all the ligands docked into the lobeline AChBP crystal structure. A reason for the lobeline 
point having the best score could be that the protein was optimized for lobeline, since it 
was co-crystallized with lobeline. Therefore, the lobeline point in figures 20a and 20b 
seems to be driving the correlation, so it was removed in order to determine whether the 
correlation actually exists or not. 
 
45 
 
DOCKING STUDIES
for Ac-Lob without water with the 
lobeline point removed.
 After removal of the 
lobeline point from the gra
(figure 20a, b
correlation between the 
expected pose Gscore and the 
pKd disappeared, figure 21a.
The new R2 value is 0.0145. 
However, the trend line still has 
a negative slope. 
lobeline point tremendously 
reduced the correlation 
the best Gscore and the pK
Figure 21. Docking Results for Ac
Without Explicit Water
Point Removed. 
removed because the data was skewed. 
The data shows the correlation between 
the Gscore and pKd. Part a shows the 
correlation between the Gscore for the 
expected pose for each ligand docked. 
b) shows the best Gscore versus the 
pKd, and c) shows the graph of the 
difference between the best Gscore and 
the expected pose Gscore versus the 
pKd. The pKd values were calculated by 
taking the log of (1/K
expressed in nanomolar units
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figure 21b. R2 for the skewed data was 0.383 and R2 for the data with the lobeline point 
removed is 0.061. Although the correlation was reduced for the “expected pose” Gscore 
and the best Gscore, it was increased for the graph of the difference between the 
“expected pose” Gscore and the best Gscore vs. pKd. The R
2 value before the point was 
removed was 0.0013, and the R2 value after removal of the lobeline point was 0.08. 
Nevertheless, comparing the lobeline graphs that were not skewed (figure 21a, b and c) 
to the aplysia hepes graphs (figure 19a, b and c), the conclusion remains that the 
lobeline AChBP structure would be the best template for an NNR homology model.  
Careful comparison of the R2 value for the “expected pose” Gscore vs. pKd for the 
aplysia hepes (figure 19a) structure was 0.075, which suggests a better correlation for 
the hepes structure than that present in the lobeline data that was not skewed (figure 
21a) which has an R2 value of 0.0145 suggests that the hepes structure would be the 
better template for NNR homology modeling. Also the R2 value from the hepes best pose 
Gscore vs. pKd graph (figure 19b) was 0.067 and lobeline structure graph of best pose 
Gscore vs. pKd that was not skewed had an R
2 value of 0.061. These data also suggest 
that the hepes structure would be the best template for NNR homology modeling.  The 
R2 values of figures 19c and 21c are 0.0503 and 0.08 respectively. In this case the data 
suggests that the lobeline structure would be the best template for NNR homology 
modeling.  Although the most of the data suggests that the hepes structure has a better 
correlation with the Gscore, the lobeline structure would still be the best template for 
NNR homology modeling because Glide 5.0 docked more of the ligands into this 
structure than in the hepes structure. 
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DOCKING STUDIES
Epibatidine Structure
 The a
epibatidine 
some major problems. Glide 
5.0 was able to dock 
out of the 19 ligands
epibatidine ligand binding 
domain. The
observed from the graph of 
the “expected pose” Gsc
vs. the pKd (figure 22a) was 
not very good, the R
was 0.1641. Also the 
correlation observed from the 
graph of the best pose 
Figure 22. Docking Results for Ac
Epi Without Explicit Water.
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the Gscore and pK
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the expected pose for each ligand 
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versus the pKd, and c) shows the 
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Gscore vs, pKd (figure 22b) was similar to that observed in figure 22a. The R
2 value was 
0.152. The slope of the trend line for figures 22a and b is positive which implies that the 
ligands with better binding affinity were assigned a more positive score and the ligands 
with worse binding affinity were assigned a more negative score, opposite to the 
expected trend.  Figure 22c shows a graph of the difference between the “expected 
pose” Gscore and the best pose Gscore vs. the pKd. The trend line from figure 22c does 
have a negative slope, which indicates that the largest change in the Gscore occurred 
for the ligands with better binding affinity. The data shown in figure 22c has an R2 value 
of 0.0052, which indicates that the correlation between the Gscore and the pKd for the 
aplysia epibatidine structure is non-existent. Based on these low correlations, the 
inverted trend and the low number of ligands that successfully dock, it appears that 
epibatidine may not be the best starting point for most NNR homology models.  
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DOCKING STUDIES
Nicotine Structure
 Glide 5.0 was able to 
dock 12 of the 19 ligands from 
the data set into the nicotine 
structure. No correlation was 
observed between the 
“expected pose” Gscore and the 
pKd (figure 23a).
has a negative slope and the 
correlation coeff
0.0002, which is worse than the 
correlation of the lobeline 
structure that was not skewed.
Figure 23b shows 
best Gscore vs. the pK
Figure 23. Docking Results 
Without Explicit Water.
shows that the correlation between the 
Gscore and pKd. Part a shows the 
correlation between the Gscore for the 
expected pose for each ligand docked. 
b) shows the best Gscore versus the 
pKd, and c) shows the graph of the 
difference between the best Gscore and 
the expected pose Gscore versus the 
pKd. The pKd values were calculated by 
taking the log of (1/K
expressed in nanomolar units
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trend line has a negative slope and the R2 value from this graph is 0.0429, which is also 
less than that of the lobeline structure where the data was not skewed by the lobeline 
point (R2 = 0.061). Finally, figure 23c shows a graph of the difference between the 
“expected pose” Gscore and the best Gscore vs. the pKd. The trend line has a negative 
slope and the R2 value for this graph was 0.0221, which was also less than that of the 
lobeline structure that was not skewed (R2 value was 0.08). These data suggest that the 
lobeline AChBP structure may be the best starting point for NNR homology modeling. 
  Interestingly, the shape of the nicotine binding site and the epibatidine binding 
site are very similar, since both ligands have a similar shape. However, nicotine was co-
crystallized with the Lymnaea species, which has a tryptophan in the place of tyrosine 55 
in the Aplysia structures. The trend lines from the epibatidine AChBP structure studies 
has a positive slope and the trend lines from the nicotine AChBP studies has a negative 
slope. The difference in the slopes of the trend lines could be due the lower resolution of 
the epibatidine structure, since the other aplysia structures (such as apo, hepes and 
lobeline) all had trend lines with a negative slope.  Since nicotine and epibatidine are 
similar in shape, the nicotine AChBP crystal structure would not be a good template for 
building a homology model into which bulkier ligands would be docked into. However, if 
one wanted to dock NNR ligands similar to nicotine and epibatidine in shape and size 
then the nicotine AChBP structure would be a good model. 
 Although, Glide 5.0 was able to dock more of the ligands into the nicotine AChBP 
structure, the R2 values were still less than that of ligands docked into the lobeline 
structure with the lobeline point removed. Since the data was scattered, no matter which 
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structure was used, the next step would be to look for a correlation between other 
scoring functions and the pKd. 
Scoring Functions 
 
 Since the Ac-Lobeline structure seemed to have the most promising correlation, 
other scoring function analyses were examined to determine if these might improve 
correlations between experimental data and the predicted binding score. Other scoring 
function analyses were also carried out on the Ls-Hepes (L-Epe) structure because it 
was the most open structure available from the Lymnaea stagnalis species. 
 The scoring functions available from Discovery Studio 2.1 package (LigScore 1 
and 2, PLP 1 and 2, Jain, PMF and PMF4, and Ludi); assign positive scores to the more 
favorable interactions. Therefore, the ligands with higher binding affinity should be 
assigned a more positive score, unlike the Gscore, where ligands with higher binding 
affinity should have been assigned a more negative score. Upon observation of the 
relationship between the pKd and the other scoring functions, no scoring function was 
identified that had a positive slope and a good R2 value.  
 To better account for key cation-π interactions in the LBD, the Quantum 
Mechanical Polarized Ligand Docking (QPLD) protocol from Schrodinger was examined. 
Table 5 indicates that of all the scoring functions studied for the lobeline AChBP, the 
QPLD Gscore was the best because the trend line had a negative slope and it had the 
best correlation with the pKd (R
2 = 0.42).  
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Figure 24. QPLD Gscore vs. pKd Graph.    
Table 5. A-Lob Other Scoring Functions. Best Score from Different scoring functions for Structures Docked into the 
Lobeline AChBP. 
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Table 6 indicates that none of the other scoring functions, including the QPLD 
Gscore, has a good correlation with the pKd for the Lymnaea hepes structure. Lack of 
correlation between the scoring functions and the pKd may be due to the difference in 
the species, in which a tyrosine in aplysia has been replaced by a tryptophan in 
lymnaea. Since tryptophan is bulkier than tyrosine, the tryptophan contributes to the 
tightness of the ligand binding domain. Therefore, there would not be as much room in 
the hepes structure as there is in the lobeline structure for the ligand to interact 
favorably. 
 
 
 
 
 
   
Table 6. L-Hepes  Other Scoring Functions. Best Score from Different Scoring function for Structures Docked into the 
L-Hepes AChBP 
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Possible Causes for Data Scatter 
Variability introduced by obtaining Kd values from different labs and by different 
experimental protocols could be a reason for the scatter of the data. In addition, the fact 
that the scoring functions do not have a term for cation-π interactions, which is believed 
to drive ligand binding to the AChBPs and NNRs, could also contribute for the scatter in 
the data. Another reason could be that the proteins are flexible and they reorient amino 
acid side chains to accommodate the ligand, however in the docking studies reported 
here the protein is frozen and only the ligand is allowed to move. Therefore, the 
interactions between the ligand and protein that would contribute to large pKd may not be 
observed in docking studies, where the protein is frozen and favorable interactions may 
be missed because the protein was not allowed to adjust to the ligand.
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CHAPTER V 
CONCLUSION 
General Conclusion 
 The AChBP ligand binding domain is located on the outside midsection of the 
protein and is at the interface of two of the five subunits that make up these 
homopentamers. The C-Loop, located on the principal face, closes over the binding 
pocket when an agonist binds. Contrastingly, upon binding of a peptide antagonist, like 
α-connotoxin, the C-Loop moves further away from the position of the C-Loop in the apo 
AChBP. As observed from the binding of an agonist and a peptide antagonist, the 
geometry of the AChBP ligand binding domain changes with ligand binding. Some of 
these changes are due to the C-loop moving to close over the top of the binding site 
allowing an agonist ligand to interact with the two tyrosines (Y188 and Y195) that are on 
both sides of the C-loop and forming a portion of the aromatic box in the LBD. Further, 
both subunits move relative to each other upon ligand binding. The C-loop for the 
lobeline structure is in roughly the same position as that found for the other small 
agonists ,i.e., epibatidine and nicotine, but residues are arranged differently to make 
room for the more extended structure of lobeline, leaving the binding pocket more open 
than the co-crystal structures of epibatidine or nicotine. Finally, as evidence of the 
repositioning of the two subunits with binding, the two subunits that make up the ligand 
binding domain for the lobeline structure are further apart from each other than any of 
the other structures.  
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 Docking of crystal structure ligands into proteins derived from the co-crystal 
structures of  epibatidine, nicotine, lobeline and imidaclopride structures (with and 
without an explicit water), was most promising for the  lobeline structure, providing the 
best average RMSD for the four ligands docked. The second set of docking studies also 
suggests the lobeline AChBP should be the best template for homology modeling, with 
Glide 5.0 successfully docking most of the ligands from the 19 ligand data. The 
correlation between the expected pose Gscore and the pKd for lobeline AChBP, as well 
as the correlation between the best Gscore and the pKd, were highest (albeit still 
modest) for docking in to this structure. 
 Glide Gscore as well as other scoring functions available within the Discovery 
Studio 2.1 suite of software were evaluated for their ability to rank the ligands by Kd 
values. Although some of the scoring functions showed slightly better correlations 
(compared to the glide Gscore) between the score and pKd for docking into the lobeline-
aplysia and lymnaea hepes structure, these correlations were not significantly better.  
Refinement of the docked poses using the Schrodinger QPLD protocol, where charges 
for initially docked poses are recalculated in the protein environment using a quantum 
mechanical approach, with subsequent redocking and scoring, did provide somewhat 
better correlations. The results reported here underscore the limitations of rigid docking 
methodologies and underscore the limitations of current scoring functions which do not 
adequately account for cation-π interactions. 
Future Studies 
 The Gscore correlation with pKd was poor and there was no promising correlation 
between any other scoring function, except for the Aplysia lobeline AChBP structure and 
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the QPLD Gscore and Coulomb van der Waals energy. However, the Kd values were 
obtained from different labs using different techniques. Once the best Gscore vs. pKd 
was graphed for the ligands docked into the lobeline structure where the Kd values were 
obtained from the same lab using the same technique, the correlation improved greatly. 
Therefore, future docking studies measuring the correlation between scoring functions 
and pKd values should be done with Kd values obtained using the same technique and 
from the same lab. Furthermore, one could design a scoring function that picks up 
cation-π interactions and look for a correlation between the scores and the pKd. Also, 
one could “train” a specific scoring function to the Kd values available. Once a good 
correlation between the score and the Kd values are obtained, one can build a NNR 
homology model using the co-crystal structure that gave the best correlation and then 
test it with the 19 ligands data set. 
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APPENDIX  D
 
Figure 25. 
Distances 
Measured—
Complementary 
to Figure 9. The 
bright green lines 
show the 
distances 
measured and 
the bright green 
spheres are 
centroids of the 
ring that they are 
in. 
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ISTANCES MEASURED 
 
